
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65580 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ondansetron
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C18H19N3OColor and Shape:White Off-White PowderMolecular weight:293.15281N6-(1-Iminoethyl)-D-lysine ((2R)-2-[(2S)-2-Aminobutanamido]butanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H17N3O2Color and Shape:White Off-White SolidMolecular weight:187.13208Rivaroxaban Desmorpholinone Analog ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H18ClN3O4SColor and Shape:White Off-White SolidMolecular weight:395.07065Fluconazole Related Compound B (2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H13FN6OColor and Shape:White PowderMolecular weight:288.11349Anastrozole
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C17H19N5Color and Shape:Off-White PowderMolecular weight:293.16405Gefitinib
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H24ClFN4O3Color and Shape:White PowderMolecular weight:446.1521Mirabegron
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C21H24N4O2SColor and Shape:White Off-White Brownish Yellow Crystalline PowderMolecular weight:396.162Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C17H14F3N3O2SColor and Shape:White SolidMolecular weight:381.07588Rotigotine Related Compound H ((S)-5-Methoxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H27NOSColor and Shape:Light Brown LiquidMolecular weight:329.18134Atazanavir S,S,S,R-diastereomer (methyl [(5S,10S,11S,14R)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7Color and Shape:Pale Yellow SolidMolecular weight:704.87Erlotinib Related Compound A (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C25H29N3O5·HClColor and Shape:Off-White PowderMolecular weight:451.21072Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C13H16N2O4Color and Shape:White Off-White SolidMolecular weight:264.11101Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClColor and Shape:White PowderMolecular weight:365.1194Fluphenazine Hydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFormula:C22H26F3N3OS·2ClHColor and Shape:White Off-White Crystalline PowderMolecular weight:509.12822Ezetimibe System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White Powder(S)-Glycidyl Phthalimide ((S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFormula:C11H9NO3Color and Shape:White Off-White SolidMolecular weight:203.05824Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C12H18O4Color and Shape:White Coarse Powder Semi-SolidMolecular weight:226.12051Atazanavir Related Compound A ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H15NO4Color and Shape:Off-White White Powder ClumpyMolecular weight:189.10011Oxcarbazepine Related Compound B (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C17H14N2O3Color and Shape:White Yellow PowderMolecular weight:294.10044Aripiprazole
CAS:Lactams, nesoiFormula:C23H27Cl2N3O2Color and Shape:White Pale Yellow PowderMolecular weight:447.14803

